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Most mental disorders, such as addictive diseases or schizophrenia, are characterized by
impaired cognitive function and behavior control originating fromdisturbanceswithin prefrontal
neural networks. Their often chronic reoccurring nature and the lack of efficient therapies
necessitate the development of new treatment strategies. Brain-computer interfaces, equipped
with multiple sensing and stimulation abilities, offer a new toolbox whose suitability for
diagnosis and therapy of mental disorders has not yet been explored. This study, therefore,
aimed to develop a biocompatible and multimodal neuroprosthesis to measure and
modulate prefrontal neurophysiological features of neuropsychiatric symptoms. We used
a 3D-printing technology to rapidly prototype customized bioelectronic implants through
robot-controlled deposition of soft silicones and a conductive platinum ink.We implanted the
device epidurally above the medial prefrontal cortex of rats and obtained auditory event-
related brain potentials in treatment-naïve animals, after alcohol administration and following
neuromodulation through implant-driven electrical brain stimulation and cortical delivery of
the anti-relapse medication naltrexone. Towards smart neuroprosthetic interfaces, we
furthermore developed machine learning algorithms to autonomously classify treatment
effects within the neural recordings. The neuroprosthesis successfully captured neural
activity patterns reflecting intact stimulus processing and alcohol-induced neural
depression. Moreover, implant-driven electrical and pharmacological stimulation enabled
successful enhancement of neural activity. A machine learning approach based on stepwise
linear discriminant analysis was able to deal with sparsity in the data and distinguished
treatments with high accuracy. Our work demonstrates the feasibility of multimodal
bioelectronic systems to monitor, modulate and identify healthy and affected brain states
with potential use in a personalized and optimized therapy of neuropsychiatric disorders.
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INTRODUCTION
The prefrontal cortex (PFC) represents a fundamental
structure for top-down behavioral control and modulates
attention, working memory, reward evaluation and the
ability to self-control actions, emotions and stress.
Disturbances of prefrontal neural network activity underlie
many cognitive and behavioral impairments observed in
neuropsychiatric diseases such as addictive disorders,
schizophrenia or autism. The complex etiology of these
diseases makes optimal treatment challenging (Gao et al.,
2012). Current therapeutical interventions often present
with side effects and lack long-term efficacy. In particular,
systemic pharmacotherapy shows poor topical specificity and
adaptability to changes in patient-specific needs regarding
treatment duration and intensity (Olofsson and Bouton,
2019). The chronic reoccurrence and high relapse rates
following treatment (Agenagnew and Kassaw, 2020) thus
warrant new approaches.
Brain stimulation techniques, such as Deep Brain
Stimulation (DBS) and transcranial Direct Current
Stimulation (tDCS), have gained increasing attention as
alternative treatment options. Predominantly applied in
Parkinson’s disease to improve motor function (Limousin
and Foltynie, 2019), DBS also showed beneficial effects in
neuropsychiatric disorders such as depression (Merkl et al.,
2013), drug addiction (Kuhn et al., 2011; Ge et al., 2019), as
well as obsessive-compulsive and anxiety disorders (Sturm
et al., 2003). However, due to its invasiveness and
continuous stimulation mode, DBS holds the risk of side
effects such as impaired speech, gait and cognition
(Buhmann et al., 2017) and has therefore been restricted to
a small number of severe and otherwise treatment-resistant
cases. In contrast, tDCS offers scalp-applied and thus non-
invasive brain stimulation with no or just minimal side effects
(Bastani and Jaberzadeh, 2012). Prefrontal tDCS has been
shown to reduce symptoms of depression (Boggio et al.,
2008) and schizophrenia (Gomes et al., 2018), as well as
craving and drug consumption in substance use disorders
(Song et al., 2019). However, reports of varying treatment
efficacy (Herrera-Melendez et al., 2020) in response to tDCS
might be due to identical stimulation parameters used for all
subjects in a rigid “one-size-fits-all” fashion not taking into
account individual differences in brain anatomy, underlying
pathology and temporal changes in brain states (Karabanov
et al., 2016). Furthermore, up to ∼75% of epicranially applied
currents are attenuated by scalp and skull (Vöröslakos et al.,
2018) hampering target region and dose specification.
Epicortical neuroprosthetics, equipped with multiple
sensing and stimulation modalities, might offer a new off-
the-beaten-track toolbox for diagnosis and therapy and may
overcome some of the limitations of current brain stimulation
techniques. Implanted epi- or subdurally and made of soft and
biocompatible materials (Minev et al., 2015; Athanasiadis
et al., 2019; Afanasenkau et al., 2020), epicortical devices
can adapt to the brain’s curvilinear surface, resulting in
reduced tissue response and improved long-term stability
compared to brain penetrating electrodes (Leuthardt et al.,
2006; Degenhart et al., 2016). Furthermore, direct cortical
stimulation via small surface electrodes provides effective
and precise stimulation close to the target structure
(Caldwell et al., 2019). Moreover, epicortical
neuroprosthesis enables combined neuromonitoring and
stimulation in one device, allowing immediate detection of
stimulation effects on neural activity. Current clinical
applications of epicortical electrodes for
electrocorticography (ECoG) and direct cortical stimulation
focus on real-time functional brain mapping to assess
language, motor and sensory function during surgical
intervention for medically intractable epilepsy and brain
tumors (Caldwell et al., 2019; Mahon et al., 2019). Besides
intraoperative epileptic seizure localization, an ECoG-type
array combined with direct cortical stimulation has been
successfully implemented to reduce an incipient seizure by
detecting abnormal neural activity that subsequently triggers
stimulation. This so-called Responsive Neurostimulation
System® (NeuroPace®, Mountain View, CA, United States )
is the first demonstration of a genuinely bidirectional, closed-
loop brain-computer interface approved for clinical
application (Sun and Morrell, 2014; Caldwell et al., 2019).
Closed-loop neuromodulation may also open opportunities
to treat neuropsychiatric disorders by utilizing artificial
intelligence and advanced machine learning algorithms to
identify brain states and optimize stimulation parameters
based on pre-defined neural features (Fellous et al., 2019).
Event-related potentials (ERPs) present eligible biomarkers for
this purpose. These short electrical deflections induced in the
brain immediately following an external or internal event have
proven valuable for investigating sensory information
processing and higher-order cognition in healthy
individuals as well as psychopathological conditions
(Sokhadze et al., 2017). Within scalp-recorded
electroencephalograms (EEG), ERPs appear as time-locked
local negative or positive maxima of a few microvolts (µV)
lasting tens to hundreds of milliseconds (ms). They are
commonly labelled according to their polarity (negative 
N, positive  P) and latency (in ms post-stimulus or order
of appearance within the recorded waveform) (Kappenman
and Luck, 2011). The best-known paradigm to elicit ERPs is
the” oddball “paradigm in which subjects are confronted with a
series of frequent (e.g., auditory or visual) stimuli
(“standards”) randomly interspersed with rare stimuli
(“deviants”). Standard ERP components observed in such
tasks include P1, N1, P2, N2 and P3. The components P1,
N1 and P2 reflect pre- and early attentive automatic stimulus
processing and sensory gating that constitutes an inhibitory
filter mechanism to focus on salient stimuli while
disregarding irrelevant or repetitive information (Lijffijt
et al., 2009). The N2 is elicited by rare events and reflects a
change-detection response sensitive to novelty and stimulus
probability (Folstein and Van Petten, 2008; Campanella et al.,
2014). Likewise, amplitudes of the P3 vary with stimulus
incidence and significance but also depend on a subject’s
motivation, attentional resources and cognitive capabilities
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(Polich, 2007; Campanella et al., 2014). Modified ERPs
indicate impaired PFC functioning and cognitive deficits
associated with neuropsychiatric diseases (Knight et al.,
1999). For example, delayed and/or reduced ERP
amplitudes have been observed in alcohol-addicted patients
and animal models (Ehlers, 1988; Cohen et al., 2002; Marco
et al., 2005; Ehlers et al., 2014). Primarily a disturbed P3
component has been related to poor behavior control and
increased relapse probability and therefore judged as a suitable
predictor for the relapse risk after drug withdrawal (Petit et al.,
2015; Luijten et al., 2016).
ERPs measured by scalp-EEG have high temporal precision
but lack spatial resolution, are sensitive to noise, and, like in tDCS,
electrical signals are partly silenced through the skull (Voss and
Paller, 2017). However, ECoG electrodes are closer to the source
of relevant brain activity and have demonstrated superior signal
sensitivity, broader bandwidth, higher topographical resolution
and a lower vulnerability to artifacts than EEG, resulting in
accurate ERP acquisition (Leuthardt et al., 2006; Krusienski
and Shih, 2010).
So far, ECoG electrodes have been placed over lateral,
sensorimotor areas based on clinical requirements for
epileptic seizure localization (Krusienski and Shih, 2010;
Mouthaan et al., 2016) or to enable paralyzed patients to
control external devices using movement-related neural
activity patterns (Vansteensel et al., 2016; Benabid et al.,
2019). However, the potential of an epicortical implant to
target cognitive ERPs from central prefrontal brain regions
remains unexplored.
Based on the advantages and opportunities of an implanted
bidirectional brain-computer interface, we set out to build a
tailor-made soft and multimodal epicortical device able to
both measure and modulate neurophysiological features
relevant to the diagnosis and therapy of neuropsychiatric
disorders. Modulation can hereby be achieved through
implant-driven electrical stimulation or local drug
application. We implanted our device epidurally above the
medial (m) PFC of rats and tested its feasibility to obtain
auditory ERPs. We detected a reduction in neuronal activity
induced by systemic acute alcohol intake. Moreover, implant-
driven neuromodulation was observed following direct cortical
application of electrical pulses and pharmacologically active
naltrexone (NTX). We furthermore deployed machine
learning algorithms to distinguish treatment-specific brain
responses from single ERP trials with potential use as
feedback for closed-loop adjustment of neurostimulation in
a therapeutic neuroprosthesis. Finally, we performed an
immunohistochemical analysis of implant and intervention
tolerability.
MATERIALS AND METHODS
Design and Fabrication of the
Neuroprosthetic Device
We initially developed a custom implantable device covering the
surface of the frontal lobe of the rat cortex. The neuroprosthetic
devices were manufactured using the 3D bioprinter
3DDiscoveryTM Evolution (regenHU Ltd., Villaz-St-Pierre,
Switzerland). The design of the implants was prepared with
the printers’ bioprinting software suite BioCADTM and in
G-code using a custom-developed Python (Version 3.7)
based software. Implants consisted of electrodes arranged in
a 3 × 3 matrix with a distance between adjacent electrodes of
1.5 mm in the mediolateral direction and 2.0 mm in the
rostrocaudal direction. According to their position above the
mPFC, electrodes were labelled as frontocentral (FC), frontal
left (FL), frontal right (FR), medial central (MC), medial left
(ML), medial right (MR), posterior central (PC), posterior left
(PL) and posterior right (PR). Eight of the electrodes (0.2 ×
0.2 mm2) were used for neural recording only. The larger FC
electrode (1 × 1 mm2) was used for both, recording and
electrical stimulation of the mPFC spanning both
hemispheres at 3.2 mm anterior to bregma. In addition, a
microfluidic channel was integrated to enable local delivery
of liquids at 2.2 mm anterior to bregma.
Arrays were 3D-printed layer-by-layer on glass slides
previously treated with a release layer (2% sodium dodecyl
sulfate). The implants were assembled with a 100 µm thick
base layer of a silicone elastomer (DOWSIL™ SE 1700, Dow
Inc., Midland, United States ) with interrupts defining the
position of the active sites of electrodes and the outlet of the
microfluidic channel (Figures 1Ai). Subsequently, borders,
determining the interconnect paths, were printed using the
same material (Figure 1Aii). Next, we deposited electrically
conductive tracks consisting of platinum powder (chemPUR,
Karlsruhe, Germany) dispersed in tri(ethylene glycol)
monomethyl ether (TGME, Merck KGaA, Darmstadt,
Germany) (Figure 1Aiii). The quality of all printing and
processing steps was evaluated under a microscope
(Supplementary Figure S1), and defects were manually
corrected. After printing each layer, the implants were placed
on a heating plate at 120°C to enable polymerization and solvent
evaporation. Then, a drop of polydimethylsiloxane (PDMS,
SYLGARDTM184, Dow Inc., Midland, United States) pre-
cured for 90 s at 90°C was manually applied at the position
of each electrode and baked on a hot plate at 105°C. The
application and baking were made for each electrode
separately to ensure rapid polymerization and prevent a
PDMS film formation covering the electrode site. To
interface the implant with external electronic devices,
stainless steel microwires (∅: 0.23 mm, 7SS-2T, Science
Products GmbH, Hofheim, Germany) were manually
attached to the interconnects with a silver-containing epoxy
adhesive (EPO-TEK® H27D, part A, Epoxy Technology Inc.,
Billerica, United States) (Figure 1Aiv). The solvent was then
evaporated at 90°C. For the microfluidic channel, a section of
soft silicone tubing (length: 1 cm, inner ∅: 0.51 mm, 45630102,
DowCorning Silastic, Freudenberg Medical Europe GmbH,
Kaiserslautern, Germany) was manually connected to the
implant with SE1700 silicone (Figures 1AV). Implants were
insulated with a PDMS layer polymerized at 90°C (Figure 1Avi).
The wire connection was insulated with a thick silicone layer
using DOW CORNING®734 (Figure 1Avii). Finally, the free
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endings of the microwires were soldiered to an off-the-shelf
connector (TC-2506280, Conrad Electronic SE, Hirschau,
Germany) and insulated with hot glue. A finished electrode
array is presented in Figure 1B.
Electrochemical ImpedanceMeasurements
The impedances of implant electrodes in vitro were recorded in
phosphate buffered saline (PBS) (pH 7.4) at room temperature
using a potentiostat equipped with a frequency response analyzer
FIGURE 1 |Multimodal epicortical array for recording and modulation of neural activity. (A) i) Silicone base layer (DOWSIL™ SE1700), including holes defining the
active sites of electrodes and the microfluidic channel. ii) A second silicone layer defines the borders for electrode interconnects and the microfluidic channel. iii) The
conductive portions of the array are formed from a platinum-silicone composite. iv) Connection of microwires. v) Connection of silicone fluidic channel. vi) Isolation of the
array using SYLGARDTM184. vii) Isolation of the cable contacts using DOW CORNING® 734. (B) Photograph of an implant (C) Implantation of the array above the
rat mPFC encompassing anterior cingulate (ACC), prelimbic (PrL) and infralimbic (IL) cortices. Stereotactic coordinates (mm) relative to bregma. (D) Impedances in vitro
(at 1 kHz) of recording (blue, n  80 electrodes of 10 implants) and stimulation electrodes (red, n  10 electrodes of 10 implants) and in vivo (varying implant numbers, see
Supplementary Table S2). Data are presented as mean ± SEM.
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(AUTOLAB PGSTAT204, Deutsche Metrohm Prozessanalytik
GmbH and Co., KG, Filderstadt, Germany). A platinum wire
served as a counter electrode and an Ag/AgCl electrode as
reference. Impedance measurements in vivo were carried out
right before each recording session using the Intan RHD2000
USB interface system (Intan Technologies, Los Angeles,
United States). The counter electrode was a stainless steel wire
(7SS-2T, Science Products GmbH, Hofheim, Germany) whose
de-insulated ending was connected to a microscrew fixed into the
interparietal bone.
Animals
All investigations within this project have been approved by the
ethics committees of the Technical University of Dresden and the
Saxonian ministry of the interior (Landesdirektion Sachsen, TVV
58/2018). Experiments were performed according to the
guidelines of the Directive 2010/63/EU on the protection of
animals used for scientific purposes of the European
Commission with great attention to avoid suffering and reduce
the number of animals used.
The study involved n  10 adult male Wistar wildtype rats
(Janvier Labs, Le Genest-Saint-Isle, France) initially housed in
groups of up to four animals. After surgery, rats were housed in
single cages (Makrolon®, Type III, Tecniplast Deutschland
GmbH, Hohenpeißenberg, Germany) on sawdust bedding
(Ssniff - Bedding 3/4 S, Altrogge, Lage, Germany) and with
Bed-r’Nest material (Datesand Ltd., Bredbury,
United Kingdom) as enrichment. Pelleted food (V1534-300,
ssniff Spezialdiäten GmbH, Soest, Germany) and water were
available ad libitum. Housing rooms were temperature
(20–22°C) and humidity (50–60%) controlled with a 12 h
automatic light-dark cycle with lights on at 6.00 am. Before
surgery, animals were habituated to the experimenter and the
recording set-up through daily handling for 2 weeks.
Implantation of the Neuroprosthesis
Surgeries to implant the bioelectronic devices were performed
under subcutaneous anesthesia with fentanyl (0.005 mg/kg),
midazolam (2.00 mg/kg), and medetomidinhydrochloride
(0.135 mg/kg) injected into a nuchal fold. An animal’s head
was fixed into a stereotactic frame via ear pins and jaw
brackets. First, the skullcap and cranial suture were exposed
and two microscrews were drilled into the skull: the first one
in the left parietal skull bone, which was later cable-connected to
the implant connector and served as a reference and the second
one in the right frontal skull bone serving as anchor screw to
improve fixation. Then, the skull was slowly trepaned (∅ 6.0 mm,
<1,500 rpm) under constant flushing with cold PBS at
−2.6–3.2 mm bregma. The dura mater was then carefully
incised bilaterally next to the position of the microchannel
outlet (2.2 mm anterior to bregma) to allow the influx of NTX
solution. The implant was placed centrally on the cortex with the
stimulation electrode located at 3.2 mm anterior to bregma
(Figure 1C). Synthetic dural sealant (1A:3B, 3–4,680, Dow
Corning, Midland, United States) was applied to the implant
to close the drill hole. The external parts of the implant were fixed
to the skull with dental cement (Paladur, Kulzer GmbH, Hanau,
Germany), and the wound was sutured. Upon completion of
surgery, anesthesia was antagonized by subcutaneous injection of
naloxon (0.12 mg/kg BW), flumazenil (0.2 mg/kg) and
atipamezole (0.75 mg/kg). Animals received meloxicam
(1.0 mg/kg, s.c.) as pain medication right after surgery and on
the following day.
ECoG Recording and Stimulation Set-Up
ECoG recordings started 3 days after surgery and were performed
at a sampling rate of 3 kHz using the Intan RHD2000 USB
interface system with the RHD2132 amplifier chip (Intan
Technologies, Los Angeles, United States), cable-connected to
the implant connector. Recordings were initially performed
without and after that—in randomized order—every 3 days
following intraperitoneal injection of 1.5 or 3 g/kg EtOH (20%
v/v, 20 min before recording), electrical or pharmacological
stimulation with NTX (Figure 2). Electrical stimulation of the
mPFC through the frontocentral electrode was applied as
biphasic, charge-imbalanced pulses (100 µA anodal/-80 µA
cathodal, 130 Hz) for 20 min before recording using a
computer-interfaced current generator (STG4004,
MultiChannelSystems, Reutlingen, Germany). For
pharmacological stimulation, NTX (Merck KGaA, Darmstadt,
Germany) was dissolved in artificial cerebrospinal fluid (125 mM
NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.3 mM MgSO4, 1.25 mM
NaH2PO4, 26 mM NaHCO3, 13 mM C6H12O6) and applied in
different dosages (3, 6 or 30 μg/μl) at a volume of 1 µl via the
implant’s microchannel 20 min before recording.
Auditory stimuli to induce ERPs were generated using
custom-written Matlab scripts (Version R2019a, The
Mathworks Inc., Natick, MA, United States) and consisted of
frequent (standards: 50 ms, 1 kHz, 70 dB SPL, 1,200 times  87%
of trials) and rare (deviants: 50 ms, 2 kHz, 80 dB SPL, 180 times 
13% of trials) sinusoidal sounds with rise and fall times of 5 ms
and with 1 s interstimulus interval. Deviant tones were
interspersed with at least one standard sound avoiding that
two deviants occurred successively. To reduce movement
artefacts, one animal at a time was placed in a rodent sling
(Lomir Biomedical Inc., Notre-Dame-de-l’Île-Perrot, Canada)
within an electrically shielded and soundproofed audiometry
booth. Sound stimuli were presented in 5 blocks of 5 min via
loudspeakers at a distance of 40 cm and an angle of 45° centrally
above the animals’ head (Figure 2).
Data Processing and Analysis
Data processing was performed using the EEGLAB toolbox
(Delorme and Makeig, 2004) (Version 2019.1) for Matlab.
Initially, data were filtered offline using a 0.1–45 Hz bandpass
FIR filter (Kaiser windowed, Kaiser β  5.65, filter length 54,330
points). Data were segmented in epochs between −100 and
700 ms relative to stimulus onset separately for standard and
deviant sounds and baseline-corrected using these epoch’s pre-
stimulus interval (−100–0 ms). Artifacts were identified and
excluded based on a delta criterion of 400 µV before averaging
epochs for single subjects and all animals (grand average),
respectively. ERP peak latencies were identified within
standard time intervals confirmed by visual inspection (P1:
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30–75 ms, N1: 80–105 ms, P2: 110–125 ms, N2: 130–180 ms, P3:
200–500 ms). The amplitudes of the ERP components were
calculated as averaged amplitudes within a time window of
10 ms around the peak latency. Amplitudes of the P2
component are N1-P2 peak-to-peak amplitudes, whereas all
other components are baseline-to-peak amplitudes.
ERP Single-Trial Classification
Filtered and artifact-free neural recording files already segmented
for standard and deviant sounds were used for single-trial ERP
classification. In addition, procedures were performed on the data
provided by the frontocentral electrode, as this was the channel in
which successful recordings were consistently available, only
missing NTX3 for one animal.
Dataset Generation for Treatment
Classification
Data were low pass filtered using a least squares linear phase anti-
aliasing FIR filter with a cut-off frequency of 32 Hz and
downsampled to 64 Hz to reduce dimensionality and the
possibility of overfitting. Time domain data were then
extracted in the ranges of the N1 (80–105 ms) and P3
(200–500 ms), resulting in a total number of 22 feature time
points per trial. Next, ERP “difference trials” for individual
sessions and animals were generated by subtracting 1) the
mean response to standard stimuli from each response to a
deviant stimulus and 2) each response to a standard stimulus
from the mean response to deviant stimuli. Applying both of
these approaches allows a more extensive training set than
performing only one of the methods. Finally, all difference
trials from all other animals were combined to form the
training data set. Difference trials from an animal undergoing
the classification procedure were excluded from the training set.
Feature Selection and Classification
Next, we performed a stepwise linear discriminant analysis
(SWLDA), chosen as a combined feature selection and
classification strategy. SWLDA has previously been proven
effective when processing ERP data (Krusienski et al., 2006),
including performing single-trial classification (Wirth et al.,
2020). Time-domain features (i.e., the voltage values recorded
at each time point, after pre-processing) were used for the feature
selection phase. SWLDA feature selection first involved creating
an initial model with no features and subsequent stepwise
regression performed on the training data. Regression analysis
was performed on potential models during each step, including or
excluding each feature in turn and producing a F-statistic with a
p-value for each feature. Smaller p-values indicated features with
the highest likelihood of being beneficial. If any feature not
already in the model had a p-value below the entry threshold
of 0.05, the feature with the smallest p-value would be added to
the model. If no features were added, but any feature currently in
the model now had a p-value above the removal threshold of 0.1,
then the feature with the highest p-value would be removed from
the model. For example, upon starting the feature selection
process for a given dataset, new models would be generated
containing each individual time-domain feature, and the
FIGURE 2 | Set-up and timeline for ECoG recording sessions. Experiments were planned as a within-subjects-design with all animals undergoing an initial
habituation period, surgical intervention and neural recordings without previous treatment (sham) and following alcohol injections, electrical brain stimulation and cortical
administrations of NTX in a randomized order. Electrical potentials elicited during the auditory oddball task were amplified and digitized at a sampling rate of 3 kHz via the
Intan RHD2000 recording system and visualized and saved on a computer using the Intan recording software.
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performance of each of these models on the training data would
be compared to the performance of the empty set. If we imagine
that a feature achieved the lowest p-value at t  250 ms, and that
this p-value was below 0.05, the model containing only this
feature would be the current model at the end of the first step.
During the second step, models containing each other available
feature, together with the feature at t  250 ms, would be
generated, and their performance on the training data would
be compared to that of the current model. If the lowest p-value
was achieved by a feature at t  90 ms, and this p-value was below
0.05, the current model at the end of the second step would be the
model containing both features at t  90 ms and t  250 ms. These
steps continued until no features were added to, or removed from,
the model. If this process failed to select any features, the single
feature with the smallest p-value would be selected. For the
classification phase, a linear discriminant analysis model was
trained and tested using the selected features. Each training trial is
represented as a point in a n-dimensional space to build the
model, where n is the number of selected features. A linear
hyperplane is then fitted in this n-dimensional space to
separate best the two sets of points representing the two
classes. The class with the fewest training trials was
oversampled to ensure that training occurred with an equal
number of trials per class. Using this method, each difference
trial in the test set from a given session was classified. In order to
obtain these single-trial classifications, the test trial was
represented as a point in the n-dimensional space. Depending
on which side of the hyperplane it lay, it would be classified as
either treatment. A simple majority vote was then carried out,
based on the classifier outputs of all test trials in the session, to
provide an overall session-level classification of which treatment
had been applied. This approach was tested on one-vs-one
combination for all interventions. For all treatment
comparisons, each session’s actual treatments and predicted
treatments were cross-tabulated to form a contingency table
on which a chi-square test was performed. The classification
of a given treatment comparison was considered statistically
significant overall if the p-value of the chi-square statistic was
less than 0.05.
Immunohistochemistry
Immunohistochemical evaluation of implant and treatment
biocompatibility were performed on three groups: 1) animals
that received the surgical intervention but no implants (sham, n
 3), 2) rats with a non-functional implant (dummy, n  3) and 3)
animals with an active implant that received a combination of
EtOH injections, electrical stimulation and NTX delivery
(treatment, n  7). After 4 weeks of implantation, rats were
perfused with PBS and paraformaldehyde (PFA), and brains
were extracted and stored at 4°C in PFA for 24 h. To dehydrate
the tissue, brains were kept in sucrose (30%) at 4°C for up to 1 week
before freezing them into methylbutan within liquid nitrogen at
−40°C for 2 min. Brains were stored at −80°C until further
processing. Brains were cut into slices of 40 µm thickness using
a microtome and kept free-floating into antifreeze medium at
−20°C until immunohistochemical staining. Staining was
performed as double-staining. From each brain, six slices were
used per double-staining. Each first slice was derived from
underneath the stimulation electrode at 3.2 mm anterior to
bregma. Consecutive sections were always 24 sections apart,
covering the complete area underneath the implant. Slices were
stained according to a standard staining protocol for free-floating
sections. Each step preceded multiple washes in PBS. Sections were
blocked in PBS containing 0.3% Triton X-100 and 10% serum for
2 h before incubation at 4°C overnight with the following primary
antibodies in blocking solution (Supplementary Table S1): glial
fibrillaric acidic protein (GFAP), ionized calcium binding adaptor
molecule 1 (Iba1), laminins and platelet endothelial cell adhesion
molecule (also known as cluster of differentiation 31 (CD31)),
hexaribonucleotide binding protein-3 (NeuN) and cysteine-
aspartic acid protease (caspase3). The following day, slices were
incubated with secondary antibodies and fluorescent dye (Table
S1) in blocking solution for 2 h before mounting on slides using
Mowiol.
Fluorescent images of the brain sections were acquired with
10x magnification using the ZEISS AxioScan.Z1 Digital Slide
Scanner. Image analysis was performed using the image
processing suite Fiji (Schindelin et al., 2012). Thereby, images
were initially background-corrected and a global threshold was
applied to extract relevant objects (Supplementary Figure S2).
We defined a region of interest (ROI) covering the entire implant
width and all cortical layers up to a depth of 2 mm for each brain
slice. The density of immunostaining (percentage of stained area
per ROI, counts of stained objects per mm2) and mean
fluorescence of the six brain slices per staining were averaged
for each animal for statistical analysis.
Statistical Analysis
Statistical analysis was carried out using SPSS® (Version 25, IBM
Corp., Armonk, NY, United States). Initial ERP data of untreated
animals underwent a one-sample t-test of the difference curve
(deviant minus standard) against zero value. Treatment-induced
modulations of neural activity were analyzed applying two-tailed
paired t-tests (α  0.05) for each treatment vs. sham condition.
The resulting p-values were corrected post-hoc for multiple
comparisons (accounting for false positives amongst the 9
channels) using the Benjamini-Hochberg procedure with a
threshold of 5% and additionally reported as FDR-adjusted
p-values. Effect sizes were calculated using Cohen’s d with
differences of means divided by their standard deviation.
Statistical analysis of immunohistochemical investigations
involved a one-way analysis of variance and Holm-Sidak post-
hoc testing comparing numbers of stained objects, percentage of
total area stained and fluorescence intensities between sham-
operated animals, rats receiving an implant dummy and
treatment conditions. Effect sizes were calculated using Cohen’s f.
RESULTS
Development of an Epicortical
Neuroprosthesis to Interface the PFC
We used a recently established prototyping technology allowing
rapid fabrication of soft and customized bioelectronic implants
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involving direct ink writing of silicones and a conductive
platinum ink (Athanasiadis et al., 2019; Afanasenkau et al.,
2020). Impedances of the soft electrodes at 1 kHz measured
in vitro were 10.14 ± 1.96 kΩ (mean ± standard error of the
mean (SEM)) for recording electrodes (n  80 from 10 implants)
and 4.36 ± 1.41 kΩ (n  10 from 10 implants) for stimulating
electrodes (Figure 1D; Supplementary Figure S3;
Supplementary Table S2).
The bioelectronic devices were implanted epidurally above the
mPFC in a delicate surgical procedure involving trepanation
directly above the superior sagittal sinus and adjacent blood
vessels. Attention was paid to limiting drilling to a few
seconds at a low drill rotational speed under constant PBS
flushing to prevent thermal tissue damage though occasional
microbleedings could not be avoided.
The stability of implants in vivo was evaluated for up to
3 weeks, during which impedances of individual electrodes
were measured every third day right before recordings. A
general trend of impedance increase was observed over time
in recording electrodes, while impedances of the stimulation
electrodes remained stable (Figure 1D; Supplementary Table
S2). Functional electrodes suitable for further ERP analysis
were defined as having an impedance below 600 kΩ.
Throughout the study period, more than 80% of electrodes
remained functional (Supplementary Table S2). However, one
of the stimulation electrodes lost functionality at the last
session time point.
Implementation of ECoG Measurements of
PFC Activity
We set out to establish if our technology is capable to reliably
obtain characteristic ERPs in awake rats (n  10). We used an
auditory oddball paradigm similar to those applied in human
ERP studies to elicit typical sound-specific ERP responses.
Differences in neural activity underlying perception of the
frequent standard and rare deviant sounds should result in
different voltage waveforms recorded through the implant.
Indeed, grand average ERPs over all animals revealed
significantly different neural activities elicited by the two
sounds with large effect sizes for P1, N1 and P3 components
at all electrode sites, also bearing FDR correction (Figure 3;
Supplementary Table S3). The components P2 and N2 were not
clearly recognisable at each electrode though significant
differences within these time intervals have been detected at
some channels (e.g., electrode FL, P2: t(9)  2.318, p  0.046
FIGURE 3 | Grand average ERPs elicited by the standard sound (blue), deviant sound (red) and their difference curves (black) at all electrode sites. Traces are
averaged from 10 animals. The components P1-N1-P2 are characteristic for pre- and early attentive auditory signal processing, while N2 and P3 indicate conscious
stimulus evaluation.
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uncorrected; N2: t(9)  -2.514, p  0.033 uncorrected) but did not
withstand FDR correction.
Electrical and Pharmacological Modulation
of Neural Activity
Following the successful acquisition of ERPs in untreated animals
(sham), we tested if we can detect changes in neural activity
induced by acute systemic alcohol administration, as well as
electrical stimulation and NTX, both applied directly to the
cortex through the implant. Following each of the
interventions, animals were subjected to the same auditory
oddball task. Unfortunately, interventions could not be
performed on all animals due to issues with connectors,
cement adhesion or blockage of the microfluidic channel,
which necessitated these animals to be dropped from the study.
In each treatment condition, neural responses to the standard
sound appeared flat, as was the case for untreated animals
(presumably due to habituation effects caused by the high rate
of repetitions). Therefore and in order to focus on treatment-
induced changes of neural activity, subsequent analysis was
performed on ERP difference curves (deviant-minus-standard
sounds).
Animals received a low (1.5 g/kg, n  6) or a high (3.0 g/kg, n 
9) dose of EtOH. Behaviourally, the low dose induced just a
slightly tottering gait, while the high dose resulted in ataxia and
immobility. Paired t-tests revealed a delay of the N2 component
at four channels in the low EtOH condition, but no significant
impact on ERP amplitudes (Figure 4A,B; Supplementary Figure
S4; Supplementary Table S4, S5). In contrast, high dosed EtOH
significantly impaired neural functioning as reflected by a
diminished N1 component Figure 4A,B; Supplementary
FIGURE 4 | Impact of alcohol and implant-driven electrical and pharmacological brain stimulation on prefrontal neural activity. (A) Representative grand average
deviant-minus-standard ERP difference curves at channel FC following administration of alcohol at 1.5 g/kg (n  6, rose) and 3 g/kg (n  9, red), electrical brain
stimulation (n  8, yellow), cortical delivery of naltrexone (NTX) at 3 μg/μl (n  5, light blue), 6 μg/μl (n  4, mid-blue), and 30 μg/μl (n  5, dark blue) and untreated animals
(sham, n  10, black). (B) ERP amplitude differences between interventions and untreated animals at all channels. Implant channels are displayed in 3 × 3 matrices
for each treatment (rows) and ERP component (columns) with suppressing or enhancing treatment effects on ERP amplitudes illustrated in blueish or reddish colors. The
bottom left inset illustrates channel locations with the highlighted FC stimulation electrode and the microfluidic channel between electrodes FC and MC. Numbers
indicate significant p-values (uncorrected).
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Figure S4; Supplementary Table S7). ERP latencies for high
EtOH were only analysed for the P1 component (Supplementary
Table S6), as other ERP components were suppressed entirely.
Next, we investigated the effects of direct cortical stimulation
on neural activity by applying biphasic, charge-imbalanced
pulses. Such waveforms have been shown to provide a good
compromise between effective neural activation and adverse
effects such as tissue damage and dissolution of platinum
electrodes (Merrill et al., 2005). Animals (n  8) did not
display behavioral changes upon stimulation, however,
increased P1, N1 and N2 amplitudes at six channels indicated
an enhancing effect of electrical stimulation on brain activity
(Figure 4A,B; Supplementary Figure S5; Supplementary Table
S9). For the N1 component, this effect was more pronounced in
closer proximity to the stimulation site as revealed by paired
t-tests using mean N1 responses combined for frontal (t(6) 
−4.703, p  0.003, |d|  0.936) and mid-row electrodes (t(6) 
−3.139, p  0.020, |d|  0.516) compared to posterior electrode
sites (Figure 4B). ERP latencies were unchanged
(Supplementary Table S8).
Finally, we investigated the effects of epicortical
administration of NTX, an opioid receptor antagonist well
established in recuperation but with just moderate effects in
conventional oral application (Hendershot et al., 2017). We
tested three different doses (3 µg (NTX3, n  5), 6 µg (NTX6,
n  4), 30 µg (NTX30, n  5)). Differences in animal behaviour
upon NTX administration at either of the applied doses were not
observed. NTX at 3 μg/μl and 30 μg/μl decreased latencies of P1
and N1 components (Supplementary Table S10, S14) and all
concentrations displayed enhancing effects on amplitudes of N1,
P2, N2 or P3 components (Figure 4A,B; Supplementary Figure
S6; Supplementary Table S11, S13, S15). However, results
remained significant following FDR-correction only at
channels near the microchannel outlet for N1 amplitudes at a
dose of 3 μg/μl (channels FC,MC, FL,ML) and 30 μg/μl (channels
FC, FL) and for the P2 at channel FL and 30 μg/μl.
Successful Single-Trial ERP Classification
Computing ERP grand averages in standard offline ERP analysis
procedures is unsuitable for a neuroprosthetic device designed to
operate in individuals in real-time. Thus, we applied machine
learning algorithms to perform single-trial classification of ERP
responses. In addition, we aimed to provide an accurate
differentiation, of which treatment had been applied to each
session for each individual.
Grand average data showed notable differences between sham
recordings and EtOH treatments, especially in the N1 and P3
components. As these ERPs are known to peak at frontocentral
electrode sites (Wronka et al., 2008; Campanella et al., 2014), FC
data of these components were chosen for feature extraction
based on voltage differences between sham recordings and
treatments. The classification procedure providing the most
accurate treatment differentiation is visualized in Figure 5.
Table 1 comprises the accuracies of the resulting predictions
for each one-vs-one session comparison. When comparing sham
condition against treatment of 3 g/kg of EtOH, the correct
treatment was predicted for 94.4% of sessions, with only one
misclassification. Furthermore, brain states induced by electrical
stimulation were correctly distinguished from all other conditions
with a precision up to 100% (low EtOH dose). Pharmacological
treatments with NTX were correctly classified in at least two-
thirds of sessions for every comparison. Contingency tables
reporting the predictions in each treatment comparison are
shown in Supplementary Table S16.
Biocompatibility of Implant Materials and
Applied Treatments
Finally, we investigated the biointegration of the device itself and
the effects of the combined interventions on brain tissue after
4 weeks of implantation. This involved immunohistochemical
evaluation of neuroinflammation by applying antibodies against
GFAP and Iba1 and stainings of laminins and CD31, revealing
cerebral vascular integrity. We furthermore investigated neuronal
cell survival by using antibodies against the neuronal marker
NeuN and caspase3, a mediator of programmed cell death.
Immunostainings were performed on sham-operated animals
without implants, animals that received a non-functional
dummy implant and rats with an active implant that
underwent EtOH injections, electrical stimulation and NTX
delivery. Zoomed-in microscopic images of Figure 6 depict
the immunoreactivity within the left motor cortex at 3.2 mm
anterior to bregma next to the stimulation electrode
(Figures 6A,B).
In line with other studies using ECoG implants (Schendel
et al., 2014; Degenhart et al., 2016), we noticed fibrous tissue
surrounding the electrode array leading to a slight depression of
brain tissue underneath. In addition, we observed a lower number
of NeuN positive cells in the treatment group (F(2,10)  4.474, p 
0.045) indicative of an effect of treatment rather than caused by
the device as animals that received an implant dummy did not
display a significant difference in %area stained and numbers of
NeuN positive cells compared to sham-operated rats (Figures
6B,C; Supplementary Table S17). Furthermore, no differences
between groups were found for GFAP, Iba1 and caspase3,
indicating that neither the dummy implant nor the treatments
induced significantly enhanced inflammation or acute cell loss
(Figures 6B,C; Supplementary Table S17). However, we
observed treatment-related cellular alterations within the
cerebral vascular system indicated by lower laminin expression
in animals of the treatment group compared to sham-operated
rats (fluorescence intensity: F(2,10)  8.793, p  0.021, %area of
ROI: F(2,10)  7.853, p  0.042) and rats with implant dummies
(fluorescence intensity: F(2,10)  8.793, p  0.021, %area of ROI:
F(2,10)  7.853, p  0.020) Figures 6B,C; Supplementary
Table S17)).
DISCUSSION
We established a multimodal neural interface combined with
machine learning to acquire, modulate and classify ERP
components in awake rats. By multimodal we mean, that our
neural interface provides bidirectional functionality through 1)
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FIGURE 5 | Approach to distinguish the treatment applied for each session. (A)Generation of training and test trials. Upper row (red): deviant ERP responses for a
single animal and treatment, including the mean (right). Mid row: standard ERP responses, including the mean (left). Bottom row: resulting difference trials. Time ranges
not used for classification are obscured in light grey. (B) Session-level feature selection results. Representing a example model for testing whether the animal’s session
can be correctly classified as ‘alcohol high’ against ‘sham’ treatment. Solid green line: mean of all difference trials under ‘sham’ treatment. Solid brown line: mean of
all difference trials under ‘alcohol high’ treatment. Shaded areas above and below these lines represent 1 standard error. Each individual feature represents the voltage at
a given time point of each trial. For example, blue dotted line represents voltages of each trial at 388 ms post-stimulus. Time ranges, not eligible for classification, are
(Continued )
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epicortical recording and 2) modulation of neural activity
through implant-driven stimulation. This stimulation can be
either electrical or pharmacological. This capacity of our
device, to record neural signals together with the ability to
stimulate in the electrical and chemical domains, contrasts
conventional EEG systems, which provide recording only, and
available stimulation techniques such as transcranial direct
current stimulation or deep brain stimulation which are only
able to stimulate. In addition, while available ECoG-based
systems typically focus on sensorimotor brain areas, this study
proposes the first-time application of an epicortical implant to
target cognitive ERPs from higher-order prefrontal networks. The
applied tools have potential applications in diagnosing and
treating neuropsychiatric diseases and aim to pave the way for
intelligent closed-loop neuroprostheses.
Custom electrode arrays were manufactured using a 3D printing
technology with robot-controlled deposition of soft and conductive
materials that allowed tailoring the implant layout to match the
surface area above the mPFC. The flexible Pt-silicone electrodes of
our arrays provided low impedances in vitro. Previous studies
demonstrate that electrode impedances increase during the first
weeks after implantation but decline over extended periods (Stiller
et al., 2020). Similarly, we observed increasing impedances at 1 kHz
of recording electrodes during the 3-weeks study period though we
did not perform measurements over longer implantation durations
to clarify if a decrease in impedances would also occur in our devices.
Impedances of stimulation electrodes were lower than recording
electrodes due to their larger surface area and remained stable over
the entire study period. A potential explanation for this may be that
electrical stimulation supposedly has a “rejuvenating” effect on the
electrode-tissue interface by decreasing the tissue interface resistance
resulting in improved signal quality and reduced electrode
impedances (Johnson et al., 2005). The stability enabled reliable
and high-quality field potential recordings.
Neuropsychiatric disorders are associated with disturbances in
prefrontal brain activity that also translate into altered ERPs. Their
monitoring is therefore increasingly supported to become part of the
clinical routine (Campanella, 2013).We recorded ERPs appearing in
the brain as early stages of auditory perception immediately after the
onset of sounds. In healthy subjects, they differ depending on sound
characteristics (e.g., pitch, loudness). Our bioelectronic implant was
capable to reliably measure these ERP differences between rare
deviant and frequent standard sounds in accordance with
previous studies using similar paradigms (Sambeth et al., 2003,
2004; Ehlers et al., 2014). Likewise, we could successfully detect
dose-dependent ERP changes following acute administration of
alcohol. In line with available data from humans and rodents, the
application of EtOH substantially affected the N1 component
indicating impaired sensory gating and perceptual disturbances
(Jääskeläinen et al., 1998; Gooding et al., 2013; Ehlers et al., 2014).
Although ERPs have been recognised as disease biomarkers
(Campanella and Colin, 2014), their targeted monitoring and
modulation is not the focus of current therapeutic interventions.
In real-life, ERP abnormalities in the context of alcohol use
disorders would express in reaction, e.g., to hearing the sound
of opening a beer bottle or seeing people drinking alcohol. In an
addicted individual, such alcohol-associated stimuli attract
attention and challenge inhibitory abilities to withstand
alcohol consumption (Campanella, 2016). These processes also
express as altered neural activity patterns that are supposed to
normalize when neuromodulation is applied to improve behavior
control and decrease relapse risk. First studies using tDCS to
correct neural disturbances in substance use disorders could
positively affect N2 and P3 components (for review see
(Habelt et al., 2020)). In our study, implant-driven direct
cortical stimulation successfully enhanced the N1, P2 or N2
components at most channels, indicating improved auditory
processing, sensory gating and enhanced perception of the
deviant stimulus. Especially for the N1 component, this effect
was more pronounced at electrodes closer to the stimulation site.
Nguyen and Lin (Nguyen and Lin, 2014) further demonstrated
that the frontal N1 might not only reflects passive sensory
processing but also indicates motivational salience shown by
increased N1 amplitudes in rats correctly responding to a
FIGURE 5 | obscured in light grey. Non-selected features are obscured in dark grey and marked with crosses above. Checkmarks for selected features and p-values of
the last iteration are shown above. (C)Classification of single trials for which a simplified example of the linear discriminant classifier is employed. For visualization, the two
features with the smallest p-values in the feature selection example shown in part (B) are extracted and the 100 samples closest to the arithmetic mean of each class are
displayed. Green circles: samples from ‘sham’ treatment. Brown triangle: samples from ‘alcohol high’ treatment. The hyperplane generated by the classification model
best separating the two classes is indicated as a dashed black line. An example test sample is shown as a blue star. This sample falls on the lower right side of the
hyperplane, and it is correctly classified as an ‘alcohol high’ sample. (D)Overall session-level classification by the model. After each test trial (as generated in part (A) and
tested as in part (C) with the features selected in part (B), the majority of trials in this example was classified as ‘alcohol high’. Therefore, the overall prediction for the
session is ‘alcohol high’.
TABLE 1 | Percentage of sessions in which the treatment was accurately
predicted for each one-vs-one treatment type comparison.
Treatment A Treatment B n Session
Classification Accuracy
p-value
Sham alcohol high 9 94.4% <0.001
Sham alcohol low 6 66.7% 0.248
Alcohol low alcohol high 6 83.3% 0.014
Sham el. stimulation 8 75.0% 0.046
Alcohol high el. stimulation 7 92.9% 0.001
Alcohol low el. stimulation 6 100.0% <0.001
Sham NTX3 4 87.5% 0.029
Sham NTX6 4 75.0% 0.103
Sham NTX30 5 90.0% 0.001
Alcohol high NTX3 3 100.0% 0.014
Alcohol high NTX6 3 83.3% 0.083
Alcohol high NTX30 4 75.0% 0.103
Alcohol low NTX3 3 66.7% 0.410
Alcohol low NTX6 3 66.7% 0.410
Alcohol low NTX30 4 75.0% 0.103
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FIGURE 6 | Immunohistochemical evaluation of implant and treatment tissue response. (A) Cross-section of rat brain and the biomedical implant at 3.2 mm
anterior to bregma including the region of interest (ROI) defined for biocompatibility analysis following device explantation and the magnified view presented in (B). (B)
Representative microscopic images of the left motor cortex at 3.2 mm anterior to bregma next to the stimulation electrode. Insets are 50 × 50 µm squares. (C) Selected
biotolerance indicators for each, six brain slices per staining of sham-operated animals (n  3), rats that received an implant dummy (n  3) and treatments (n  7) are
normalized and presented as mean ± SEM. Asterisks indicate significant differences (p < 0.05).
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reward-coupled deviant sound compared to miss responses.
Therefore, modulating the N1 component could influence
early inhibition of stimulus-activated actions (Debruille et al.,
2019), which is relevant to addictive diseases because relapse, as
previously mentioned, is triggered by drug cue-induced craving
and impaired inhibitory control (Campanella, 2016).
Abnormalities in stimulus-locked P2 and N2 have also been
associated with drug users who discontinued treatment (Steele
et al., 2014; Fink et al., 2016), suggesting that monitoring and
modulation of these components could predict and influence
treatment outcomes. The P3 component was not significantly
influenced by stimulation here. However, the P3 is more
pronounced in practical tasks involving active action planning
and behaviour control than under passive conditions as applied
here (Wronka et al., 2008).
Upon local delivery of NTX directly onto the PFC, we
observed decreased latencies of P1 and N1 components (3 μg/
μl and 30 μg/μl) and increased amplitudes of N1, P2, N2 or P3 (all
doses applied) at several channels pointing to improved auditory
processing. Although already approved in 1984 for addiction
treatment (United.States Department of Health and Human
Services, 2009), investigations of NTX effects on
electrophysiological parameters are sparse and inconclusive.
Earlier EEG studies could not detect an influence of systemic
NTX application on the ERPs of our interest: in an auditory
oddball paradigm with social drinkers, previous oral intake of
NTX significantly reduced the late negative difference at
200–500 ms post-stimulus indicative for an NTX-induced
impaired selective attention (Jääskeläinen et al., 1998). In
contrast, a somewhat improved neural functioning by NTX
was concluded from an increased language-related N4 in a
semantic memory task performed by opioid addicts, long-term
treated with NTX via an abdominal subcutaneous implant
(Sheng-xi et al., 2009).
Towards autonomous identification of brain states evoked by
neuromodulation and pharmacological treatment, single-trial
ERP data underwent a machine learning procedure involving
SWLDA. SWLDA has a strong track record in the classification
of P3-related data and has again performed well here. The
comparison between sham condition and a high dose of
alcohol was classified correctly in 17 out of 18 sessions, with
a high degree of statistical significance (p < 0.001). Interestingly,
the administration of the two different doses of alcohol was
accurately distinguished, supporting recent findings in which
machine learning approaches revealed that ERPs correlate with
individual differences in alcohol consumption behaviour in
patients suffering from alcohol use disorders (O’Halloran
et al., 2020). Machine learning techniques using ERP
components have proven to differentiate patients from
healthy controls also in schizophrenia (Neuhaus et al., 2013),
attention deficit hyperactive disorder (Mueller et al., 2010) and
autism (Eldridge et al., 2014). Importantly, our SWLDA
approach could identify animals that received direct cortical
stimulation. This is crucial for the development of closed-loop
neuroprosthetics, which intend to reduce side effects and
increase efficiency by switching on brain stimulation only if
and as long as an abnormal neural activity is detected, adaptively
adjusting stimulation parameters and switching off as soon as
brain activity has been normalised (Parastarfeizabadi and
Kouzani, 2017). Besides the NeuroPace® RNS® System for
epilepsy, a closed-loop system utilizing a machine learning
approach was successfully implemented for DBS in
Parkinson’s disease to extract patient-specific cortical signals
that indicate tremor-evoking movement and adjust stimulation
voltage in real-time (Houston et al., 2019). ERPs and machine
learning can thus support the diagnosis of psychiatric symptoms
and contribute to developing predictions about disease
progression and treatment outcomes in individual subjects,
enabling a personalized and optimized therapy (Campanella,
2013; Thieme et al., 2020).
Although we have successfully demonstrated the suitability
of our biomedical implant to obtain and modulate prefrontal
ERPs, the safety of neural implants is crucial.
Immunohistochemical analysis revealed good
biocompatibility of the used implant materials, while animals
in the treatment group displayed some variability in their
cortical morphology. Note that animals received alcohol,
electrical stimulation and local delivery of NTX. Therefore
we cannot tell if the effects shown are caused by a specific
treatment or result from interactions of treatments. However,
this might reflect a clinical scenario where patients are treated
with a combination of different approaches.
Differences in immunoreactivity were predominantly
observed for laminins, a family of glycoproteins that belong to
the extracellular matrix and are relevant to blood-brain-barrier
and neuronal functioning (Lasek, 2016). Therefore, the detected
decrease in expression of laminins likely affected neurons as well.
Surgical interventions to implant biomedical interfaces include
neural and vascular injury and typical foreign body reactions to
the implanted devices (Prodanov and Delbeke, 2016). Here, the
necessary incision of the dura mater to allow the influx of NTX
solution likely induced some vascular damage causing the
observed changes in laminin expression in some animals.
However, vascular dysfunction and neuronal loss have also
been associated with oxidative stress caused by alcohol abuse
(Alikunju et al., 2011). Knabbe and colleagues (Knabbe et al.,
2020) demonstrated that even a single intoxicating exposure to
alcohol has long-lasting molecular and cellular effects on the
brain. Electrical stimulation is capable of increasing the
permeability of the blood-brain barrier as well. However, this
effect is transient and reversible (Shin et al., 2020). Studies
applying DBS suggest that electrical stimulation might regulate
and even reduce neuroinflammation and apoptosis, thus exerting
a neuroprotective effect (McKinnon et al., 2019). Further,
alcohol-induced neurodegeneration has been associated with
enhanced microglial and astrocytic expression (Saito et al.,
2016). However, we did not observe significantly enhanced
GFAP and Iba1 immunoreactivity in the treatment group.
Since NTX has been shown to have anti-inflammatory and
neuroprotective functions counteracting drug-induced
activation of astrocytes, microglia and caspase3 (Hutchinson
et al., 2011; Qin and Crews, 2012), we conjecture that NTX
might have inhibited the potential damaging effects of repeated
alcohol administration.
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LIMITATIONS
With the here applied passive auditory oddball paradigm, it is
impossible to clarify if targeted ERP normalisation through an
epicortical implant can re-establish lost behavior control. This
would necessitate an experimental approach requiring subjects to
actively respond to or inhibit their response to certain stimuli (Kutas
et al., 2012). When applied e.g., in addiction models, stimuli can be
paired with the availability and self-administration of drugs. The
implant would then monitor and modulate neurophysiological
correlates of drug-cue reactivity and associated drug seeking and
consumption behaviour. As validated animal models are available
(Nestler and Hyman, 2010), the experimental set-up presented here
can be used straightway to target a wide range of neuropsychiatric
disorders where disturbed prefrontal processing is a characteristic
feature closely related to the clinical symptomatology, cognitive
impairments and poor functional outcomes (Ramsay et al., 2020).
Neural measurements were currently performed following
stimulation, and their analysis was carried out offline. These
elements need to be combined to enable autonomous
measurement, analysis, and modulation of neural activity in
real-time. In addition, integration of a controllable liquid
infusion unit might allow a more precise cortical drug delivery.
The used machine learning procedures to identify different
treatment conditions were chosen on the assumption that linear
classifiers perform well in the classification of brain signals
compared to more complex approaches such as deep neural
networks as they offer the possibility of overfitting, due to
relatively small data sets usually being available (Lotte et al.,
2007). However, in this scenario, the training data set is made up
of trials from numerous animals. If a large cohort of animals is
used, there may be enough training data to make deep learning an
attractive alternative approach. In the current data set, the
stimulation electrode was the only channel consistently
recorded in all sessions for all animals. Increased reliability of
channel recordings may be advantageous to classification,
allowing more spatial information to be utilized. The current
approach relies on patterns being learned in a group of animals
and transferred to a different test animal. However, brain signals
are known to suffer from variability (Polich, 2007). Further
sessions of all conditions would allow calibration trials from
the test animal’s other sessions to build a better model to
generalize to a new session. With data from multiple sessions
of each condition, it may be possible to build fully subject-
dependent models for each animal, which may aid accuracy.
Finally, for analysis of treatment-induced tissue reactions, rats
received a combination of interventions that hinder the allocation
of the outcomes to a specific treatment. Moreover,
biocompatibility evaluations should be performed after
prolonged, clinically relevant implantation durations assessing
persistent effects (Prodanov and Delbeke, 2016).
CONCLUSION
Here, we established a 3D printed flexible and biocompatible
epicortical implant for monitoring ERPs of the rat mPFC.
Thereby, the manifestation of typical auditory ERPs expected
to occur in healthy individuals as well as alcohol-induced
neural impairments were successfully acquired through the
device. Furthermore, implant-driven electrical and
pharmacological stimulation enabled a measurable
modulation of neural activity that has been classified
autonomously through new machine learning algorithms
able to deal with sparse data. Though further investigations
are needed to demonstrate the utility of our approach for
functional recovery from pathological behaviour, these results
are promising and underline the great potential of
bioelectronic medicine in the diagnosis and therapy of
mental disorders.
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